Vivani Medical regains compliance with Nasdaq minimum bid price rule

Vivani Medical, Inc.

Received Nasdaq deficiency notice on Dec 26, 2023 for bid price below $1 for 30 consecutive days.
On Jan 9, 2024, Nasdaq confirmed compliance after 10 consecutive business days at $1 or above (Dec 22 to Jan 8).
Delisting risk removed; Nasdaq considers the matter closed.

item 8.01 item 9.01

Vivani Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001753926-24-000087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.